Mark F. McCarty. “Flavones and Flavonols May Have Clinical Potential As CK2 Inhibitors in Cancer Therapy”. Cancer Studies and Molecular Medicine , vol. 2, no. 1, Mar. 2015, pp. 39-51, doi:10.17140/CSMMOJ-2-105.